AbbVie Stock: A Superficially-Bullish Narrative

2022-07-23 01:03:56 By : Mr. Tony Wang

While medical procedures during the height of the COVID-19 crisis focused on addressing the pandemic, as society normalizes, the spotlight is now shining on elective procedures, thus benefiting pharmaceutical giant AbbVie.